Anixa Biosciences (ANIX) Preferred Shares (2014 - 2018)

Anixa Biosciences' (ANIX) quarterly Preferred Shares came in at $3.5 million in Q4 2018, up 24900.0% on a QoQ basis from $14000.0 in Q4 2016.

Anixa Biosciences (ANIX) Preferred Shares (2014 - 2018) Analysis & Trends

Anixa Biosciences (ANIX) has 4 years of Preferred Shares data on file, last reported at $3.5 million in Q4 2018.

Quarterly Preferred Shares changed N/A year-over-year to $3.5 million in Q4 2018, while the trailing twelve-month figure through Oct 2018 was $3.5 million (changed N/A YoY) and the FY2018 annual result came in at $3.5 million, changed N/A from the prior year.
Preferred Shares rose to $3.5 million in Q4 2018, from $14000.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $3.5 million in Q4 2018 to a low of $14000.0 in Q4 2014.
A 4-year average of $422545.5 and a median of $14000.0 in 2014 frame the typical range for Preferred Shares.
The widest YoY moves for Preferred Shares: up 0.0% in 2015, down 96.0% in 2015.
Tracing ANIX's Preferred Shares over 4 years: stood at $14000.0 in 2014, then changed by 0.0% to $14000.0 in 2015, then changed by 0.0% to $14000.0 in 2016, then soared by 24900.0% to $3.5 million in 2018.
The last three Preferred Shares figures came in at $3.5 million (Q4 2018), $14000.0 (Q4 2016), and $14000.0 (Q3 2016), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	138.60 Bn	130.75 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.93 Bn	77.93 Bn	3.93 Bn	-
3	Argenx Se	65.06 Bn	59.88 Bn	1.37 Bn	-
4	Moderna	56.22 Bn	51.08 Bn	52.00 Mn	-
5	BeOne Medicines	42.03 Bn	36.93 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.65 Bn	28.34 Bn	992.69 Mn	-
7	BioNTech SE	27.70 Bn	9.31 Bn	668.28 Mn	-
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
9	Royalty Pharma	27.31 Bn	26.48 Bn	-	-
10	Anixa Biosciences	123.96 Mn	123.96 Mn	-	-

Download Data